The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Atezolizumab (atezo) with or without Bacille Calmette-Guérin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study.
 
Noah M. Hahn
Honoraria - Bladder Cancer Academy; PeerView; PlatformQ Health
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Champions Oncology; CicloMed; Ferring; Genentech/Roche; GlaxoSmithKline; Health Advances; Incyte; Janssen; Merck; Mirati Therapeutics; Pfizer/EMD Serono; Principa Biopharma; Seattle Genetics/Astellas; Taris BioMedical; Trans Med
Research Funding - Acerta Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); HTG Molecular Diagnostics (Inst); Incyte (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Seattle Genetics/Astellas (Inst)
 
Gary D. Steinberg
Stock and Other Ownership Interests - Epivax Therapeutics; Urogen pharma
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical
 
Kelly Lynn Stratton
Honoraria - Bayer; Dendreon (Inst); Oakstone Publishing; Sun Pharma
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Large Urology Group Practice Association (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Bayer
Research Funding - Advantage Pharmaceuticals (Inst); Anchiano (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Ryan P. Kopp
Honoraria - Pfizer
Research Funding - Merck Sharp & Dohme Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - ConMed
 
Alexander Sankin
Honoraria - Photocure
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Ambu; Ethicon; MSD; Photocure
 
Eila C. Skinner
Research Funding - Genentech/Roche
 
Kamal S. Pohar
Honoraria - Photocure
Consulting or Advisory Role - Photocure
Research Funding - E.R. Squibb Sons, LLC (Inst); Karl Storz (Inst); MSD (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Covidien; MSD; Photocure
 
Benjamin Adam Gartrell
Honoraria - Janssen
Consulting or Advisory Role - Janssen
 
Song Pham
Employment - Roche
 
Deepali Rishipathak
Employment - Genentech
 
Sanjeev Mariathasan
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Nicole N. Davarpanah
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Corey Carter
No Relationships to Disclose
 
Brant Allen Inman
Consulting or Advisory Role - Boston Biomedical; Combat Medical; Ferring; Genentech; Nucleix
Research Funding - Anchiano (Inst); Combat Medical (Inst); Dendreon (Inst); FKD Therapies (Inst); Genentech/Roche (Inst); QED Therapeutics (Inst); Taris BioMedical (Inst); Urogen pharma (Inst)